Evaluation of different pharmacokinetically guided IV busulfan exposure ranges on adult patient outcomes after hematopoietic stem cell transplantation Article Early Access

cited authors

  • Mori, Shahram; Guo, Mengni; Rivera-Robles, Nahir; Edgar, Cory Mical; Mcvey, Courtney Paige; Yi, Fanchao; Ahmad, Sarfraz; Patel, Rushang D.; Varela, Juan Carlos

authors

Publication Date

  • December 3, 2022

webpage

published in

category

keywords

  • Allogeneic hematopoietic stem cell transplantation
  • Busulfan
  • Graft-versus-host disease
  • Minimal residual disease
  • Pharmacokinetics
  • Survival outcomes